Anticancer drug erlotinib price
Erlotinib has been officially launched in China and is included in medical insurance, with prices ranging from a few dozen yuan to six to seven hundred yuan. There are also officially marketed generic versions overseas, available in two specifications: 100mg and 150mg. The latest market price is about one thousand yuan. Patients can choose to purchase suitable drugs based on their personal needs.
This drug is mainly used to treat locally advanced or metastatic non-small cell lung cancer (NSCLC) that has received at least one chemotherapy regimen but failed to achieve good results. Although clinical studies have shown that erlotinib also has some therapeutic potential in pancreatic cancer and other types of solid tumors, these indications have not yet been widely recognized.

The recommended dosage is 150 mg per day. Patients should take it one hour before or two hours after meals to ensure optimal absorption. During the treatment process, patients need to persist in taking the medication until disease progression or unbearable toxic reactions occur. In some cases, if a patient experiences serious adverse reactions, the doctor may recommend adjusting the dose or temporarily discontinuing the drug.
While taking erlotinib, it is important for patients to inform their doctor about their medical conditions and other medications they are taking to avoid potential drug interactions. Follow your doctor's dosage recommendations and do not adjust the dosage on your own. At the same time, regular doctor examinations and evaluations are performed to monitor the progression of the disease and the effectiveness of the medications.
Patients also need to pay attention to their own body reactions and seek medical attention promptly if any abnormal symptoms or adverse reactions occur. By working closely with their physician, patients can manage their condition more effectively and maximize the effectiveness of their treatment. When choosing to use erlotinib, fully understanding its indications, usage, and possible adverse reactions will help patients make informed decisions and better cope with challenges during the disease and treatment process.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)